Trajectories of Body Mass Index and Risk for Diabetes Complications and All-Cause Mortality in Finnish Type 2 Diabetes Patients

References

• Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metabol Syndr Obes. 2013;327–338. doi:10.2147/DMSO.S51325
   PubMedGoogle Scholar
• Type 2 diabetes Current Care Guidelines. A working group set up by the Duodecim of the Finnish Medical Associations, the Finnish Association of Internal Medicine Physicians and the Medical Council of the Diabetes Association. Available from: www.kaypahoito.fi/hoi50056. Accessed May 18, 2020.
   Google Scholar
• American Diabetes Association. 8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement_1):S100–S110.
   PubMedGoogle Scholar
• Wing RR; Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Inter Med. 2010;170(17):1566–1575. doi:10.1001/archinternmed.2010.334
   PubMedGoogle Scholar
• Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481–1486. doi:10.2337/dc10-2415
   PubMed Web of Science ®Google Scholar
• Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Physical Ther. 2008;88(11):1322–1335. doi:10.2522/ptj.20080008
   PubMed Web of Science ®Google Scholar
• Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16. doi:10.1007/s00125-018-4711-2
   PubMed Web of Science ®Google Scholar
• Eeg-Olofsson K, Cederholm J, Nilsson P, et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia. 2009;52(1):65–73. doi:10.1007/s00125-008-1190-x
   PubMed Web of Science ®Google Scholar
• Svensson M, Tyrberg M, Nyström L, et al. The risk for diabetic nephropathy is low in young adults in a 17‐year follow‐up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors. Diabetes Metab Res Rev. 2015;31(2):138–146. doi:10.1002/dmrr.2574
   PubMed Web of Science ®Google Scholar
• Bentata Y, Abouqal R. Paradoxical association between body mass index, renal progression, and cardiovascular disease in elderly adults with type 2 diabetes mellitus. J Am Geriatr Soc. 2014;62(10):2002–2004. doi:10.1111/jgs.13058
   PubMed Web of Science ®Google Scholar
• Li W, Katzmarzyk PT, Horswell R, et al. Body mass index and stroke risk among patients with type 2 diabetes mellitus. Stroke. 2015;46(1):164–169. doi:10.1161/STROKEAHA.114.006718
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes?: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Inter Med. 1997;157(6):650–656. doi:10.1001/archinte.1997.00440270094008
   PubMedGoogle Scholar
• Mohsen A, Brown R, Hoefield R, et al. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus. J Nephrol. 2012;25(3):384–393. doi:10.5301/jn.5000062
   PubMed Web of Science ®Google Scholar
• Kwon Y, Kim HJ, Park S, Park YG, Cho KH, Kaser S. Body mass index-related mortality in patients with type 2 diabetes and heterogeneity in obesity paradox studies: a dose-response meta-analysis. PLoS One. 2017;12(1):e0168247. doi:10.1371/journal.pone.0168247
   PubMed Web of Science ®Google Scholar
• Aucott LS, Philip S, Avenell A, Afolabi E, Sattar N, Wild S. Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study. BMJ open. 2016;6(7):e010836. doi:10.1136/bmjopen-2015-010836
   PubMed Web of Science ®Google Scholar
• Yeboah P, Hsu F-C, Bertoni AG, Yeboah J. Body mass index, change in weight, body weight variability and outcomes in type 2 diabetes mellitus (from the ACCORD Trial). Am j Cardiol. 2019;123(4):576–581. doi:10.1016/j.amjcard.2018.11.016
   PubMed Web of Science ®Google Scholar
• Kaze AD, Santhanam P, Erqou S, Ahima RS, Bertoni AG, Echouffo-Tcheugui JB. Body weight variability and risk of cardiovascular outcomes and death in the context of weight loss intervention among patients with type 2 diabetes. JAMA Network Open. 2022;5(2):e220055–e220055. doi:10.1001/jamanetworkopen.2022.0055
   PubMed Web of Science ®Google Scholar
• Nam GE, Kim W, Han K, et al. Body weight variability and the risk of cardiovascular outcomes and mortality in patients with type 2 diabetes: a nationwide cohort study. Diabetes Care. 2020;43(9):2234–2241. doi:10.2337/dc19-2552
   PubMed Web of Science ®Google Scholar
• Ceriello A, Lucisano G, Prattichizzo F, et al. Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register. Cardiovasc Diabetol. 2021;20(1):1–10. doi:10.1186/s12933-021-01360-0
   PubMed Web of Science ®Google Scholar
• Yang Z, Shen P, Qu Y, et al. Baseline and longitudinal trajectories of body-mass index and all-cause mortality among patients with type 2 diabetes. Diabetes Metabol. 2023;49(3):101426. doi:10.1016/j.diabet.2023.101426
   PubMed Web of Science ®Google Scholar
• Lamidi M-L, Wikström K, Inglin L, Rautiainen P, Tirkkonen H, Laatikainen T. Trends in the process and outcome indicators of type 2 diabetes care: a cohort study from Eastern Finland, 2012–2017. BMC Family Practice. 2020;21(1):1–11. doi:10.1186/s12875-020-01324-5
   PubMed Web of Science ®Google Scholar
• Wikström K, Lamidi M-L, Rautiainen P, Tirkkonen H, Kivinen P, Laatikainen T. The effect of the integration of health services on health care usage among patients with type 2 diabetes in North Karelia, Finland. BMC Health Serv Res. 2021;21(1):1–9. doi:10.1186/s12913-021-06059-2
   PubMedGoogle Scholar
• Inglin L, Lavikainen P, Jalkanen K, Laatikainen T. LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model. Sci Rep. 2021;11(1):22603. doi:10.1038/s41598-021-02077-6
   PubMed Web of Science ®Google Scholar
• Lavikainen P, Aarnio E, Linna M, et al. Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes. PLoS One. 2022;17(6):e0269245. doi:10.1371/journal.pone.0269245
   PubMed Web of Science ®Google Scholar
• Brämer GR. International statistical classification of diseases and related health problems. Tenth revision. World Health Statist Quarter. 1988;41(1):32–36.
   PubMedGoogle Scholar
• Nordic Medico-Statistical Committee. NOMESCO classification of surgical procedures (NCSP), version 1.15. Nordic Medico-Statistical Committee (NOMESCO); 2011.
   Google Scholar
• Jung T, Wickrama KA. An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Psychol Compass. 2008;2(1):302–317. doi:10.1111/j.1751-9004.2007.00054.x
   Google Scholar
• Berlin KS, Parra GR, Williams NA. An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models. J Pediatric Psychol. 2014;39(2):188–203. doi:10.1093/jpepsy/jst085
   PubMed Web of Science ®Google Scholar
• Nagin DS. Analyzing developmental trajectories: a semiparametric, group-based approach. Psychological Methods. 1999;4(2):139. doi:10.1037/1082-989X.4.2.139
   Web of Science ®Google Scholar
• Muthén B, Shedden K. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics. 1999;55(2):463–469. doi:10.1111/j.0006-341X.1999.00463.x
   PubMed Web of Science ®Google Scholar
• Reinecke J, Seddig D. Growth mixture models in longitudinal research. AStA Adv Statis Anal. 2011;95(4):415–434. doi:10.1007/s10182-011-0171-4
   Web of Science ®Google Scholar
• Collins LM, Schafer JL, Kam C-M. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychological Methods. 2001;6(4):330. doi:10.1037/1082-989X.6.4.330
   PubMed Web of Science ®Google Scholar
• Wardenaar K. Latent Class Growth Analysis and Growth Mixture Modeling using R: a tutorial for two R-packages and a comparison with Mplus; 2020.
   Google Scholar
• Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Ann Rev Clin Psychol. 2010;6(1):109–138. doi:10.1146/annurev.clinpsy.121208.131413
   PubMed Web of Science ®Google Scholar
• Tein J-Y, Coxe S, Cham H. Statistical power to detect the correct number of classes in latent profile analysis. Struct Equat Model. 2013;20(4):640–657. doi:10.1080/10705511.2013.824781
   PubMed Web of Science ®Google Scholar
• Nylund-Gibson K, Choi AY. Ten frequently asked questions about latent class analysis. Transl Issues Psychol Sci. 2018;4(4):440. doi:10.1037/tps0000176
   Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. doi:10.1080/00273171.2011.568786
   PubMed Web of Science ®Google Scholar
• Jensen BW, Watson C, Geifman N, Baker JL, Badrick E, Renehan AG. Weight changes in type 2 diabetes and cancer risk: a latent class trajectory model study. Obesity Facts. 2022;15(2):150–159. doi:10.1159/000520200
   PubMed Web of Science ®Google Scholar
• Nguyen DV, Shaw LC, Grant MB. Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol. 2012;3:170. doi:10.3389/fendo.2012.00170
   PubMedGoogle Scholar
• Huang D, Refaat M, Mohammedi K, Jayyousi A, Al Suwaidi J, Abi Khalil C. Macrovascular complications in patients with diabetes and prediabetes. Biomed Res Int. 2017;2017:1–9. doi:10.1155/2017/7839101
   Web of Science ®Google Scholar
• Stone MA, Charpentier G, Doggen K, et al. Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care. 2013;36(9):2628–2638. doi:10.2337/dc12-1759
   PubMed Web of Science ®Google Scholar
• Bae J, Lage M, Mo D, Nelson D, Hoogwerf B. Obesity and glycemic control in patients with diabetes mellitus: analysis of physician electronic health records in the US from 2009–2011. J diabet complicat. 2016;30(2):212–220. doi:10.1016/j.jdiacomp.2015.11.016
   Google Scholar
• Boye KS, Lage MJ, Shinde S, Thieu V, Bae JP. Trends in HbA1c and body mass index among individuals with type 2 diabetes: evidence from a US database 2012–2019. Diabetes Therapy. 2021;12(7):2077–2087. doi:10.1007/s13300-021-01084-0
   PubMed Web of Science ®Google Scholar
• Bansal P, Upadhyay HP, Jha R. Correlation between body mass index and lipid profile in a diabetic population of central Nepal. J Coll Med Sci. 2018;14(4):184–188. doi:10.3126/jcmsn.v14i4.21997
   Google Scholar
• Akinjinmi A, Amballi A, Abdulrahman AO, et al. Relationship between serum leptin, lipid metabolism, HbA1c, and renal function in individuals with type 2 diabetes mellitus and obesity and in individuals with type 2 diabetes mellitus without obesity. medRxiv. 2023. doi:10.1101/2023.02.20.23286131
   Google Scholar
• Sonmez A, Yumuk V, Haymana C, et al. Impact of obesity on the metabolic control of type 2 diabetes: results of the Turkish nationwide survey of glycemic and other metabolic parameters of patients with diabetes mellitus (TEMD obesity study). Obesity Facts. 2019;12(2):167–178. doi:10.1159/000496624
   PubMed Web of Science ®Google Scholar
• Chaudhary GMD, Din ATU, Chaudhary FMD, et al. Association of obesity indicators with hypertension in type 2 diabetes mellitus patients. Cureus. 2019;11(7):1–5.
   Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Inter Med. 1994;154(19):2169–2178. doi:10.1001/archinte.1994.00420190068008
   PubMedGoogle Scholar
• Rema M, Srivastava B, Anitha B, Deepa R, Mohan V. Association of serum lipids with diabetic retinopathy in urban South Indians—the Chennai urban rural epidemiology study (CURES) eye study—2. Diabetic Med. 2006;23(9):1029–1036. doi:10.1111/j.1464-5491.2006.01890.x
   PubMed Web of Science ®Google Scholar
• Hurst C, Thinkhamrop B, Tran HT. The association between hypertension comorbidity and microvascular complications in type 2 diabetes patients: a nationwide cross-sectional study in Thailand. Diabet Metabol J. 2015;39(5):395–404. doi:10.4093/dmj.2015.39.5.395
   PubMed Web of Science ®Google Scholar
• Turner R, Holman R, Matthews D, et al. Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens. 1993;11(3):103–113. doi:10.1097/00004872-199301000-00015
   PubMed Web of Science ®Google Scholar
• Howard BV, Robbins DC, Sievers ML, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart Study. Arteriosclerosis Thrombosis Vasc Biol. 2000;20(3):830–835. doi:10.1161/01.ATV.20.3.830
   PubMed Web of Science ®Google Scholar
• Curtis AB, Karki R, Hattoum A, Sharma UC. Arrhythmias in patients≥ 80 years of age: pathophysiology, management, and outcomes. J Am Coll Cardiol. 2018;71(18):2041–2057. doi:10.1016/j.jacc.2018.03.019
   PubMed Web of Science ®Google Scholar
• Rodgers JL, Jones J, Bolleddu SI, et al. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis. 2019;6(2):19. doi:10.3390/jcdd6020019
   PubMed Web of Science ®Google Scholar
• Zoungas S, Woodward M, Li Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465–2474. doi:10.1007/s00125-014-3369-7
   PubMed Web of Science ®Google Scholar
• Yao X, Zhang J, Zhang X, et al. Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study. Front Endocrinol. 2023;14:1131395. doi:10.3389/fendo.2023.1131395
   PubMed Web of Science ®Google Scholar
• Polemiti E, Baudry J, Kuxhaus O, et al. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study. Diabetologia. 2021;64(4):814–825. doi:10.1007/s00125-020-05362-7
   PubMed Web of Science ®Google Scholar
• Koh ES, Do Han K, Kim MK, et al. Weight change and microvascular outcomes in patients with new-onset diabetes: a nationwide cohort study. Korean J Inter Med. 2021;36(4):932. doi:10.3904/kjim.2020.121
   PubMed Web of Science ®Google Scholar
• Cho E, Manson JE, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care. 2002;25(7):1142–1148. doi:10.2337/diacare.25.7.1142
   PubMed Web of Science ®Google Scholar
• Kim MK, Han K, Koh ES, et al. Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study. Cardiovasc diabetol. 2019;18(1):1–12. doi:10.1186/s12933-019-0838-9
   PubMedGoogle Scholar
• Strelitz J, Lawlor ER, Wu Y, et al. Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials. Diabetologia. 2022;65:1–16.
   PubMed Web of Science ®Google Scholar
• Chiolero A, Peytremann‐Bridevaux I, Paccaud F. Associations between obesity and health conditions may be overestimated if self-reported body mass index is used. Obesity Rev. 2007;8(4):373–374. doi:10.1111/j.1467-789X.2007.00375.x
   PubMed Web of Science ®Google Scholar
• Gazeivood JD, Mehr DR. Diagnosis and management of weight loss in the elderly. J Fam Pract. 1998;47(1):19–25.
   PubMed Web of Science ®Google Scholar
• Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87(4):801–809. doi:10.1093/ajcn/87.4.801
   PubMed Web of Science ®Google Scholar
• Chen S-P, Peng L-N, Lin M-H, Lai H-Y, Hwang S-J, Chen L-K. Evaluating probability of cancer among older people with unexplained, unintentional weight loss. Arch Gerontol Geriatr. 2010;50:S27–S29.
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Ewing SK, Stone KL, et al. Intentional and unintentional weight loss increase bone loss and Hip fracture risk in older women. J Am Geriatr Soc. 2003;51(12):1740–1747. doi:10.1046/j.1532-5415.2003.51558.x
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Lennon L. Reasons for intentional weight loss, unintentional weight loss, and mortality in older men. Arch Inter Med. 2005;165(9):1035–1040. doi:10.1001/archinte.165.9.1035
   PubMedGoogle Scholar
• Carnethon MR, De Chavez PJD, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581–590. doi:10.1001/jama.2012.9282
   PubMed Web of Science ®Google Scholar
• Costanzo P, Cleland JG, Pellicori P, et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann Internal Med. 2015;162(9):610–618. doi:10.7326/M14-1551
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang X, Wang J, Li Y, Ying D, Yuan H. Weight loss increases all-cause mortality in overweight or obese patients with diabetes: a meta-analysis. Medicine. 2018;97(35):e12075.
   PubMed Web of Science ®Google Scholar
• Ebeling M, Rau R, Malmström H, Ahlbom A, Modig K. The rate by which mortality increase with age is the same for those who experienced chronic disease as for the general population. Age Ageing. 2021;50(5):1633–1640. doi:10.1093/ageing/afab085
   PubMed Web of Science ®Google Scholar